目的 探讨儿童川崎病(KD)并发冠状动脉损害(CAL)的危险因素。方法 回顾性分析895例KD患儿的病历资料,将其分为并发CAL 组(n=284)和未并发CAL 的对照组(n=611),比较两组临床及实验室指标,并对KD 患儿并发CAL的危险因素进行多因素logistic 回归分析。结果 男性、发生CAL 以外并发症、不典型KD、静脉注射丙种球蛋白(IVIG)抵抗、IVIG 治疗前发热时间>5 d、血清降钙素原(PCT)增高为KD患儿并发CAL 的独立危险因素(OR 值分别为1.712、2.028、3.655、2.912、1.350、1.068,均P<0.05),而血清白蛋白(ALB)较高为保护性因素(OR=0.931,P<0.05)。血清PCT 与ALB 预测KD 患儿并发CAL的曲线下面积(AUC)分别为0.631、0.558。结论 男性KD患儿、不典型KD 患儿以及发生CAL 以外并发症、发热时间较长、IVIG 治疗抵抗的KD患儿并发CAL 的风险较高。血清PCT与ALB预测KD患儿并发CAL的价值不大。
Abstract
Objective To explore the risk factors for coronary artery lesions (CAL) secondary to Kawasaki disease (KD) in children.Methods The medical data of 895 children with KD were retrospectively reviewed. The patients were classified into two groups according to the presence of CAL:CAL (n=284) and control (n=611). The clinical and laboratory indices were compared between the two groups.The risk factors for the development of CAL in children with KD were identified by multiple logistic regression analysis.Results Male gender (OR=1.712), occurrence of non-CAL complications (OR=2.028), atypical KD (OR=3.655), intravenous immunoglobulin (IVIG) resistance (OR=2.912), more than 5 days of fever duration before IVIG treatment (OR=1.350), and increased serum procalcitonin (PCT) level (OR=1.068) were the independent risk factors for the development of CAL in children with KD (P<0.05), whereas increased serum albumin (Alb) level was a protective factor (OR=0.931, P<0.05). The areas under the receiver operating characteristic curve of serum PCT and ALB for prediction of the development of CAL in children with KD were 0.631 and 0.558, respectively.Conclusions Male gender, atypical KD, occurrence of other non-CAL complications, long duration of fever and IVIG resistance are associated with an increased risk for CAL in children with KD. Serum PCT and ALB have little value in the prediction of CAL in children with KD.
关键词
川崎病 /
冠状动脉损害 /
危险因素 /
儿童
Key words
Kawasaki disease /
Coronary artery lesion /
Risk factor /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Newburger JW, TakahashiM, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin [J]. N Engl J Med, 1986, 315(6):341-347.
[2] Sato YZ, Molkara DP, Daniels LB, et al. Cardiovascular biomarkers in acute kawasaki disease[J]. Int J Cardiol, 2013, 164(1):58-63.
[3] Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease[J]. Circulation, 2006, 113(22):2606-2612.
[4] 仇慧仙, 阮妙华, 陈其, 等. 血清氨基末端脑钠肽对川崎病冠 状动脉病变预测价值的研究[J]. 医学研究杂志, 2012, 41(4):166-168.
[5] 赵建美, 王晓华. 川崎病患儿血清抗内皮细胞抗体和抗中 性粒细胞胞浆抗体检测的临床意义[J]. 中国当代儿科杂志, 2014, 16(7):740-744.
[6] Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease [J]. Pediatr Int, 2005, 47(6):711-732.
[7] 胡亚美, 江载芳. 诸福棠实用儿科学[M]. 第7 版. 北京:人 民卫生出版社, 2002:698-705.
[8] 罗泽民, 樊映红, 刘德松. 小儿川崎病冠状动脉损伤危险因 素分析[J]. 现代预防医学, 2012, 39(6):1385-1388.
[9] 陈伟, 张宏艳, 林书祥. CASP3 基因多态性与川崎病及其冠 状动脉损害易感性的关系[J]. 山东医药, 2013, 53(20):22-24.
[10] 陈晶晶, 黄敏, 谢利剑, 等. 川崎病冠状动脉损害高危因素 的研究[J]. 临床儿科杂志,2009, 27(5):442-445.
[11] 周丽玲. 肺炎支原体感染对川崎病患儿冠状动脉病变的影响[J]. 实用临床医药杂志, 2014, 18(7):149-151.
[12] 史翠平, 张宏艳. TGFBR2 基因多态性与川崎病和冠状动脉 损伤相关性的研究[J]. 中国当代儿科杂志, 2013, 15(9):767-770.
[13] 李焰, 王献民, 柳颐龄, 等. 川崎病患儿并发冠状动脉病变 的危险因素分析[J]. 中国当代儿科杂志, 2012, 14(12):938-941.
[14] 许煊. 24 例儿童川崎病的早期诊断及冠状动脉扩张高危因 素分析[J]. 暨南大学学报(医学版), 2005, 26(2):255-257.
[15] Baker AL, Lu M, Minich LL, et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease[J]. J Pediatr, 2009, 154(4):592-595.
[16] Eladawy M, Dominguez SR, Anderson MS, et a1. Abnormal liver panel in acute Kawasaki disease[J]. Pediatr Infect Dis J, 2011, 30(2):141-144.
[17] 张春雨, 刘丽丽, 廖莹, 等. 血浆前白蛋白联合C-反应蛋白 对川崎病患儿冠状动脉病变的预测[J]. 北京大学学报(医学 版), 2013, 45(2):207-210.
[18] 孟祥春, 马伟科, 胡宇慧, 等. 川崎病患儿血清PCT 变化 及其与冠状动脉损害的关系研究[J]. 医学研究杂志, 2013, 42(1):169-171.
PDF(1335 KB)
